Cubist Pharmaceuticals Inc Achieves 18% Growth in Total Net Product Revenues for Cubicin in 2011
M2 EquityBites › January 10, 2012
Linked as:
Summary
M2 EQUITYBITES-January 10, 2012-Cubist Pharmaceuticals Inc achieves 18% growth in total net product revenues for CUBICIN in 2011
(C)1994-2012 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Cubist Pharmaceuticals Inc Achieves 18% Growth in Total Net Product Revenues for Cubicin in 2011
Biopharmaceutical company Cubist Pharm...
See the full content of this document
Sponsored links
